Dear Reader

In this the final issue of Drugs in R&D for 2014, the editors and production staff at Adis would like to take the opportunity to look back on all that has been achieved in the last 12 months and to thank the people who have given their time to ensure we continue to bring you world-class content.

We are pleased to advise you of a number of positive developments involving the Adis journals in 2014. This year saw the journal portfolio increase in size with the transfer of a number of existing Springer journals into the Adis portfolio, as well as the launch of two new open access titles: *Drugs - Real World Outcomes* targets research involving the use of real-world data to evaluate health outcomes and inform healthcare decision-making, with a particular focus on healthcare-related 'big data'; and *Drug Safety - Case Reports* publishes reports of any unintended or adverse effects following administration of a medicinal product, as well as cases involving 'near misses' or a lack of efficacy.

Several of our journals saw healthy gains in the ISI impact factor this year. The biggest gains were made by *Molecular Diagnosis & Therapy*, which leapt 53 % to 2.589; *European Journal of Drug Metabolism and Pharmacokinetics*, which increased 39 % to 1.312; *American Journal of Clinical Dermatology*, which increased 37 % to 2.519; *Targeted Oncology*, which increased 25 % to 3.458; and *The Patient - Patient-Centered Outcomes Research*, which increased 25 % to 1.957. We look forward to building on these gains in 2015.

The first six titles to be commissioned under the Adis Books programme will have been published by year end and we are developing a robust pipeline of new titles, involving top authors from around the globe. We have appreciated the many topical proposals submitted to date.

As another year draws to a close, we would like to say a big thank you to all the authors who have contributed articles to Drugs in R&D. Without their expertise and hard work we would not have been able to publish the journal. The quality of published articles also reflects the significant time and effort put in by the peer reviewers, whose dedication ensures that we continue to publish content of the highest possible standard. In addition to the members of our Honorary Editorial Board, we would like to thank the following individuals who acted as reviewers for articles published in Drugs in R&D in 2014:
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We hope that you have found the articles published throughout 2014 to be both interesting and informative. The editors have appreciated the high quality of content contributed to the journal this year and look forward to keeping you up to date with topical issues in 2015.

With best wishes from the staff of Drugs in R&D and all at Adis Publications.
